Advertisement

Topics

FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults

12:23 EDT 16 May 2018 | FDA

FDA approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

Original Article: FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults

NEXT ARTICLE

More From BioPortfolio on "FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...